AI-Designed Drugs in Clinical Trials: What Has Actually Been Shown
Rentosertib began phase 3 in September 2026, but no AI-designed drug has completed one. Here is what the trials, registries and success-rate data actually show.
Science, Technology and the Physics Underneath